放射線治療の世界市場：製品タイプ、処置、用途、エンドユーザー別-2024年～2030年予測

放射線治療の世界市場規模は2023年に66億4,000万米ドルと推計され、2024年には70億3,000万米ドルに達し、CAGR 6.04%で2030年には100億1,000万米ドルに達すると予測されています。

放射線治療の世界は、がんや一部の非悪性疾患の治療法として放射線を利用する医療・ヘルスケア分野のビジネスです。X線、ガンマ線、荷電粒子線などの高エネルギー放射線を照射し、主にがん細胞の破壊、増殖の抑制、緩和的な症状の軽減を行う。がん治療への放射線治療の世界の採用が増加し、低侵襲治療への嗜好が高まっていることが、放射線治療の世界の開発に影響を与えています。対照的に、高額な治療費、訓練を受けた専門家の限られた利用可能性、放射線被曝に伴うリスクが放射線治療の世界の利用を制限しています。しかし、これらの問題を克服するために、いくつかのベンダーが研究開発に取り組んでいます。さらに、放射線治療の世界デバイスの技術的進歩や改良、がん治療用ロボット放射線治療の世界システムの導入は、最先端のデバイスを開発し販売するビジネスチャンスでもあります。

製品腫瘍部位に高線量を照射するハードウェア製造プロセスの進歩

ハードウェアには、放射線治療の世界治療を実施する際に使用される有形要素がすべて包含されています。リニアック、ブラキセラピー、陽子線治療、サイバーナイフシステムなどが含まれます。ソフトウェア・サービス部門は、治療プロトコルの計画、放射線量のシミュレーション、患者データと分析の管理に使用されるプラットフォームを指します。サービスには、機器のメンテナンス、トレーニング、技術サポート、コンサルティングなど、さまざまなサポート機能が含まれます。比較すると、ハードウェアは治療を提供する物理的手段を提供し、ソフトウェアとサービスは正確なターゲティング、線量計画、シームレスな運用を保証します。

タイプ外部ビーム放射線治療の世界/teletherapyは、腫瘍の外側や大きな腫瘍を標的にするため、消費者は外部ビームを好みます。

外部照射（EBRT）/遠隔療法は、一般的な放射線治療の一形態であり、放射線は患者の体外から発生し、がん部位に照射されます。従来のコバルト60の遠隔治療装置は、がん治療のために連続的に回転する放射線治療を提供し、より深い浸透能力を持つ非常に効率的な装置です。リニアック（LINAC）は、高エネルギーのX線を患者の腫瘍部位に照射し、がん細胞の遺伝物質を損傷し、増殖を阻害します。従来の線形加速器は、マイクロ波技術を利用して電子を加速してから重金属ターゲットに衝突させ、高エネルギーX線を発生させる。サイバーナイフ・トモセラピーは、腫瘍に複数の角度から放射線を照射するロボットアームによる精密治療を可能にします。システムオンモジュールは放射線量を調節し、健康な組織への影響を最小限に抑えます。ガンマナイフは、患部に正確な線量の放射線を照射し、健康な脳組織へのダメージを軽減します。MRIリニアックにより、臨床医は治療中の腫瘍をリアルタイムで視覚化し、必要に応じて治療を適応させることができます。定位先進電子/コバルト60リニアックでは、複数の角度から高線量の放射線を照射し、狭い範囲をピンポイントで治療するため、周囲の健康な組織への影響を最小限に抑えることができます。粒子線治療システムは、荷電粒子を使用してがん細胞を正確に狙い撃ちすることで、周辺の健康な組織への放射線量を最小限に抑え、副作用のリスクを低減できる可能性があります。内照射放射線治療の世界/Brachytherapyでは、がん部位とその近傍に直接放射線を照射し、周囲の健康な組織を温存しながら高線量を照射します。前立腺がんや子宮頸がんなどの局所がんを治療する際に、最も選択されることが多いです。アフターローダーは、放射線医療従事者の被ばくを減らし、患者の安全に対する方針を強化し、治療の精度を高めることを目的としています。アプリケーターは、放射線源を患者の体内の治療部位に位置決めするのを補助する目的で設計された器具です。術中放射線治療（IORT）システムは、局所がん治療のために手術中に使用される高度な放射線治療機器です。シードは放射性物質を封入した小さな装置です。このシードを慎重にがん組織に埋め込むと、腫瘍に直接放射線を照射することができ、周辺の健康な組織へのダメージを最小限に抑えることができます。

イオベングアン（i-131）は、ある種の神経組織に選択的に吸収される分子の一種です。このユニークな特性により、神経内分泌腫瘍の診断と治療において非常に貴重なツールとなります。レニウム-186アイソトープは、そのガンマ線特性により、医療従事者が医療用画像技術で患者の効果を追跡できるようにする模範的な方法によって、先進医療をさらに一歩前進させる。サマリウム-153は、ベータ粒子ががん細胞を標的にして破壊し、ガンマ線の放出が画像化と体内分布の追跡を容易にするという、二重の能力を備えています。

手順プロセスを合理化し、患者の快適性を向上させるための外部ビーム放射線治療の世界の高度化

外部ビーム治療（EBRT）は、様々ながんの治療に用いられる最も代表的な治療法です。3Dコンフォーマル放射線治療の世界は多くの種類のがんを効果的に治療し、その精度と副作用を最小限に抑える能力で高く評価されています。画像ガイド下放射線治療（IGRT）は、治療中の画像技術を伴う先進的な放射線治療です。強度変調放射線治療（IMRT）は、放射線治療ビームを腫瘍の形状に合わせて最適化することで、がんの様々な部分に異なる強度の放射線を照射することができます。粒子線治療は、荷電した原子粒子を使用し、その粒子が通過する組織に低線量を与え、そのエネルギーを正確なポイントに集中させるというユニークな治療法です。定位治療では、特に脳やその他の部位の小さくて境界明瞭な腫瘍に高線量を照射することができ、同時に隣接する正常組織への放射線を最小限に抑えることができるため、潜在的な副作用を軽減することができます。注入療法放射線治療の世界では、体腔や膀胱に放射性物質を直接注入し、表在性のがんを治療します。ブラキセラピーは、放射性線源を腫瘍の内部または隣に配置するもので、健康な組織を温存しながら高線量の放射線を確実に照射します。高線量率（HDR）ブラキセラピーは、周囲の健康な組織への被ばくや損傷を最小限に抑えながら、がん細胞を破壊することを目的としています。LDRブラキセラピーは、子宮頸がん、前立腺がん、眼がんを含む多くの種類のがんの治療に広く使用されています。パルスドーズレート（PDR）ブラキセラピーでは、時間的に限定された放射線照射サイクルで、通常1時間に1回、パルス状に放射線を照射します。この手法では、周囲の健康な組織を保護しながら、腫瘍への線量照射を最大化することを目指します。静脈内投与放射線治療の世界では、液体の放射性物質を静脈から体内に投与します。この治療は通常、転移したがんに用いられます。経口放射線治療の世界では、錠剤や液体で放射性物質を摂取します。甲状腺がんなどの治療に用いられます。全身療法は、全身を循環する放射性医薬品を使用するもので、骨や複数の部位に転移したがんの治療に適しています。

応用：拡大する放射線治療の世界の婦人科がんへの応用

放射線治療の世界は乳がん治療において重要な役割を果たしており、手術後の乳房内での再発リスクを大幅に低減しています。子宮頸がん治療では、放射線治療の世界が単独または化学療法と併用されることが多いです。放射線治療の世界の必要性は、がんの病期と局在に大きく依存します。大腸がん治療の放射線治療の世界は、腫瘍を縮小させるために手術前に使用され、残存細胞を死滅させるために手術後に使用されます。放射線療法は、さまざまなタイプの婦人科がんの治療によく用いられます。がんの種類や病期に応じて、放射線は一次療法、補助療法、緩和療法として用いられます。放射線治療の世界は頭頸部がんの管理において重要であり、しばしば手術や化学療法と併用されます。肺がんの放射線治療の世界は、主要な治療法として機能します。陰茎がんはまれではあるが、放射線療法を一次治療または補助治療として用いることが多いです。放射線治療の世界は限局性前立腺がんの根治的治療に非常に有効です。それに比べ、放射線治療の世界は合併症が少なく、局所制御と生存が得られるため、婦人科がんに多く使用されています。

エンドユーザー：放射線治療の世界は、がん患者の包括的ケアを提供する病院サービスにおいて重要な役割を果たします。

病院は、診断および治療サービスを含む、がん患者の包括的なケアを提供しています。放射線治療の世界を病院内の統合サービスとして提供することで、より良いケアの連携が可能となり、患者の予後改善につながります。独立した放射線治療の世界センターは、がん患者に放射線治療を提供する専門クリニックです。これらのセンターは、患者により個別化された便利な治療を提供します。これらの施設は部分的なサービスを提供することもあるが、病院はより効率的で患者中心の放射線治療の世界治療を提供できることが多いです。病院は通常、より幅広いサービスを提供しており、複数の健康問題を抱える患者を対象に、総合的なケアを提供することができます。一方、独立した放射線治療の世界センターは、より患者中心のアプローチを提供し、放射線治療の世界のみを求める患者に好まれています。

地域別の洞察

南北アメリカにおける放射線治療の世界の普及は、主にがん罹患率の増加や非侵襲的治療法への嗜好など、様々な要因によって推進されています。3Dコンフォーマル放射線治療の世界（3D CRT）や強度変調放射線治療の世界（IMRT）などの先進技術がこの市場の成長に貢献しています。同時に、がんの予防と制御に焦点を当てた政府の取り組みも、この市場拡大の大きな要因となっています。EMEA地域では、がん罹患率の上昇により放射線治療の世界に対するニーズが高まっています。同地域では多様ながん症例が観察されており、放射線治療の世界は的を絞った効率的な治療結果を提供する治療ソリューションとして好まれています。革新的な放射線治療の世界デバイスに対する規制当局の承認、がん研究の普及、強固なヘルスケアフレームワークが市場をさらに強化しています。APAC地域では、がん罹患率の上昇を背景に放射線治療の世界市場が急拡大しています。いくつかの国ではがん罹患率が高く、放射線治療の世界を含む効果的な治療法の必要性を煽っています。この分野の成長は、早期診断に対する意識の高まり、がん治療へのアクセスの改善、この分野における技術の進歩によって増幅されています。また、APACの新興国はヘルスケアインフラに多額の投資を行っており、放射線治療の世界の採用をさらに後押ししています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは放射線治療の世界市場の評価において極めて重要です。事業戦略や製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、放射線治療の世界市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2.市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3.市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4.競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5.製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1.放射線治療の世界市場の市場規模および予測は？

2.放射線治療の世界市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3.放射線治療の世界市場の技術動向と規制枠組みは？

4.放射線治療の世界市場における主要ベンダーの市場シェアは？

5.放射線治療の世界市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • がん治療における放射線治療の世界手順の採用増加
    • 低侵襲手術への関心の高まり
    • 放射線治療の世界に関する政府の取り組みとプログラムの増加
  • 抑制要因
    • 治療費が高く、訓練を受けた専門家が不足している
  • 機会
    • 放射線治療の世界デバイスの技術的進歩と改善
    • がん治療用ロボットシステムのイントロダクション
  • 課題
    • 放射線被曝に伴うリスク
• 市場セグメンテーション分析
  • 製品：腫瘍部位に高線量の放射線を照射するハードウェア製造プロセスの進歩
  • タイプ：外部から腫瘍を標的とし、大きな腫瘍を標的とする外部放射線治療/遠隔治療に対する消費者の好み
  • 手順：外部ビームの進歩によりプロセスの合理化と患者の快適性の向上を実現
  • 応用：婦人科がんに対する放射線治療の世界の応用拡大
  • エンドユーザー：がん患者に包括的なケアを提供する病院サービスにとって、放射線治療の世界は重要な役割を果たします。
• 市場ディスラプション分析
• ポーターのファイブフォース分析
• バリューチェーンとクリティカルパス分析
• 価格分析
• 技術分析
• 特許分析
• 貿易分析
• 規制枠組みの分析

第6章 放射線治療の世界市場：製品別

• ハードウェア
• ソフトウェアとサービス

第7章 放射線治療の世界市場：タイプ別

• 外部放射線治療/遠隔治療
• 内部照射放射線治療/近接放射線治療
• 体系的な放射線治療の世界

第8章 放射線治療の世界市場：処置別

• 外部ビーム放射線治療の世界
• 導入放射線治療の世界
• 内部ビーム放射線治療の世界または近接照射療法
• 静脈内放射線治療の世界
• 口頭放射線治療
• 体系的な放射線治療の世界

第9章 放射線治療の世界市場：用途別

• 乳がん
• 子宮頸がん
• 大腸がん
• 婦人科がん
• 頭頸部がん
• 肺がん
• 陰茎がん
• 前立腺がん

第10章 放射線治療の世界市場：エンドユーザー別

• 病院
• 独立した放射線治療の世界センター

第11章 南北アメリカの放射線治療の世界市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第12章 アジア太平洋の放射線治療の世界市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第13章 欧州・中東・アフリカの放射線治療の世界市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第14章 競合情勢

• 市場シェア分析、2023年
• FPNVポジショニングマトリックス、2023年
• 競合シナリオ分析
  • CIVCO放射線治療の世界とQfixがCQメディカルブランドを立ち上げ
  • GEヘルスケア、エレクタと提携しインドにおける精密放射線治療ソリューションへのアクセスを拡大
  • IBAが最新の放射線治療品質保証サービスを開始
• 戦略分析と提言

第15章 競合ポートフォリオ

• 主要企業プロファイル
• 主要製品ポートフォリオ

LIST OF FIGURES

• FIGURE 1. RADIOTHERAPY MARKET RESEARCH PROCESS
• FIGURE 2. RADIOTHERAPY MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL RADIOTHERAPY MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL RADIOTHERAPY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
• FIGURE 5. GLOBAL RADIOTHERAPY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. RADIOTHERAPY MARKET DYNAMICS
• FIGURE 7. GLOBAL RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 8. GLOBAL RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 9. GLOBAL RADIOTHERAPY MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 10. GLOBAL RADIOTHERAPY MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 11. GLOBAL RADIOTHERAPY MARKET SIZE, BY PROCEDURE, 2023 VS 2030 (%)
• FIGURE 12. GLOBAL RADIOTHERAPY MARKET SIZE, BY PROCEDURE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 13. GLOBAL RADIOTHERAPY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 14. GLOBAL RADIOTHERAPY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 15. GLOBAL RADIOTHERAPY MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 16. GLOBAL RADIOTHERAPY MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 17. AMERICAS RADIOTHERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 18. AMERICAS RADIOTHERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 19. UNITED STATES RADIOTHERAPY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 20. UNITED STATES RADIOTHERAPY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 21. ASIA-PACIFIC RADIOTHERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 22. ASIA-PACIFIC RADIOTHERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 23. EUROPE, MIDDLE EAST & AFRICA RADIOTHERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 24. EUROPE, MIDDLE EAST & AFRICA RADIOTHERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 25. RADIOTHERAPY MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 26. RADIOTHERAPY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. RADIOTHERAPY MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL RADIOTHERAPY MARKET SIZE, 2018-2023 (USD MILLION)
• TABLE 4. GLOBAL RADIOTHERAPY MARKET SIZE, 2024-2030 (USD MILLION)
• TABLE 5. GLOBAL RADIOTHERAPY MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 6. GLOBAL RADIOTHERAPY MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 7. GLOBAL RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 8. GLOBAL RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 9. GLOBAL RADIOTHERAPY MARKET SIZE, BY HARDWARE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 10. GLOBAL RADIOTHERAPY MARKET SIZE, BY HARDWARE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 11. GLOBAL RADIOTHERAPY MARKET SIZE, BY SOFTWARE & SERVICE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 12. GLOBAL RADIOTHERAPY MARKET SIZE, BY SOFTWARE & SERVICE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 13. GLOBAL RADIOTHERAPY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 14. GLOBAL RADIOTHERAPY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 15. GLOBAL RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY/TELETHERAPY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 16. GLOBAL RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY/TELETHERAPY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 17. GLOBAL RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY/TELETHERAPY, 2018-2023 (USD MILLION)
• TABLE 18. GLOBAL RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY/TELETHERAPY, 2024-2030 (USD MILLION)
• TABLE 19. GLOBAL RADIOTHERAPY MARKET SIZE, BY CONVENTIONAL CABALT-60 TELETHERAPY UNITS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 20. GLOBAL RADIOTHERAPY MARKET SIZE, BY CONVENTIONAL CABALT-60 TELETHERAPY UNITS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 21. GLOBAL RADIOTHERAPY MARKET SIZE, BY LINEAR ACCELERATORS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 22. GLOBAL RADIOTHERAPY MARKET SIZE, BY LINEAR ACCELERATORS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 23. GLOBAL RADIOTHERAPY MARKET SIZE, BY LINEAR ACCELERATORS, 2018-2023 (USD MILLION)
• TABLE 24. GLOBAL RADIOTHERAPY MARKET SIZE, BY LINEAR ACCELERATORS, 2024-2030 (USD MILLION)
• TABLE 25. GLOBAL RADIOTHERAPY MARKET SIZE, BY CONVENTIONAL LINEAR ACCELERATORS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 26. GLOBAL RADIOTHERAPY MARKET SIZE, BY CONVENTIONAL LINEAR ACCELERATORS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 27. GLOBAL RADIOTHERAPY MARKET SIZE, BY CYBERKNIFE TOMOTHERAPY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 28. GLOBAL RADIOTHERAPY MARKET SIZE, BY CYBERKNIFE TOMOTHERAPY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 29. GLOBAL RADIOTHERAPY MARKET SIZE, BY GAMMA KNIFE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 30. GLOBAL RADIOTHERAPY MARKET SIZE, BY GAMMA KNIFE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 31. GLOBAL RADIOTHERAPY MARKET SIZE, BY MRI LINAC, BY REGION, 2018-2023 (USD MILLION)
• TABLE 32. GLOBAL RADIOTHERAPY MARKET SIZE, BY MRI LINAC, BY REGION, 2024-2030 (USD MILLION)
• TABLE 33. GLOBAL RADIOTHERAPY MARKET SIZE, BY STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINEAR ACCELERATORS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 34. GLOBAL RADIOTHERAPY MARKET SIZE, BY STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINEAR ACCELERATORS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 35. GLOBAL RADIOTHERAPY MARKET SIZE, BY PARTICLE THERAPY SYSTEMS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 36. GLOBAL RADIOTHERAPY MARKET SIZE, BY PARTICLE THERAPY SYSTEMS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 37. GLOBAL RADIOTHERAPY MARKET SIZE, BY PARTICLE THERAPY SYSTEMS, 2018-2023 (USD MILLION)
• TABLE 38. GLOBAL RADIOTHERAPY MARKET SIZE, BY PARTICLE THERAPY SYSTEMS, 2024-2030 (USD MILLION)
• TABLE 39. GLOBAL RADIOTHERAPY MARKET SIZE, BY CYCLOTRONS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 40. GLOBAL RADIOTHERAPY MARKET SIZE, BY CYCLOTRONS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 41. GLOBAL RADIOTHERAPY MARKET SIZE, BY SYNCHROCYCLOTRON, BY REGION, 2018-2023 (USD MILLION)
• TABLE 42. GLOBAL RADIOTHERAPY MARKET SIZE, BY SYNCHROCYCLOTRON, BY REGION, 2024-2030 (USD MILLION)
• TABLE 43. GLOBAL RADIOTHERAPY MARKET SIZE, BY SYNCHROTRONS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 44. GLOBAL RADIOTHERAPY MARKET SIZE, BY SYNCHROTRONS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 45. GLOBAL RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 46. GLOBAL RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 47. GLOBAL RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY, 2018-2023 (USD MILLION)
• TABLE 48. GLOBAL RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY, 2024-2030 (USD MILLION)
• TABLE 49. GLOBAL RADIOTHERAPY MARKET SIZE, BY AFTERLOADERS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 50. GLOBAL RADIOTHERAPY MARKET SIZE, BY AFTERLOADERS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 51. GLOBAL RADIOTHERAPY MARKET SIZE, BY APPLICATORS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 52. GLOBAL RADIOTHERAPY MARKET SIZE, BY APPLICATORS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 53. GLOBAL RADIOTHERAPY MARKET SIZE, BY IORT SYSTEMS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 54. GLOBAL RADIOTHERAPY MARKET SIZE, BY IORT SYSTEMS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 55. GLOBAL RADIOTHERAPY MARKET SIZE, BY SEEDS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 56. GLOBAL RADIOTHERAPY MARKET SIZE, BY SEEDS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 57. GLOBAL RADIOTHERAPY MARKET SIZE, BY SYSTEMIC RADIOTHERAPY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 58. GLOBAL RADIOTHERAPY MARKET SIZE, BY SYSTEMIC RADIOTHERAPY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 59. GLOBAL RADIOTHERAPY MARKET SIZE, BY SYSTEMIC RADIOTHERAPY, 2018-2023 (USD MILLION)
• TABLE 60. GLOBAL RADIOTHERAPY MARKET SIZE, BY SYSTEMIC RADIOTHERAPY, 2024-2030 (USD MILLION)
• TABLE 61. GLOBAL RADIOTHERAPY MARKET SIZE, BY LOBENGUANE (L-131), BY REGION, 2018-2023 (USD MILLION)
• TABLE 62. GLOBAL RADIOTHERAPY MARKET SIZE, BY LOBENGUANE (L-131), BY REGION, 2024-2030 (USD MILLION)
• TABLE 63. GLOBAL RADIOTHERAPY MARKET SIZE, BY RHENIUM-186, BY REGION, 2018-2023 (USD MILLION)
• TABLE 64. GLOBAL RADIOTHERAPY MARKET SIZE, BY RHENIUM-186, BY REGION, 2024-2030 (USD MILLION)
• TABLE 65. GLOBAL RADIOTHERAPY MARKET SIZE, BY SAMARIUM-153, BY REGION, 2018-2023 (USD MILLION)
• TABLE 66. GLOBAL RADIOTHERAPY MARKET SIZE, BY SAMARIUM-153, BY REGION, 2024-2030 (USD MILLION)
• TABLE 67. GLOBAL RADIOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2023 (USD MILLION)
• TABLE 68. GLOBAL RADIOTHERAPY MARKET SIZE, BY PROCEDURE, 2024-2030 (USD MILLION)
• TABLE 69. GLOBAL RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 70. GLOBAL RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 71. GLOBAL RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY, 2018-2023 (USD MILLION)
• TABLE 72. GLOBAL RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY, 2024-2030 (USD MILLION)
• TABLE 73. GLOBAL RADIOTHERAPY MARKET SIZE, BY 3D CONFORMAL RADIOTHERAPY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 74. GLOBAL RADIOTHERAPY MARKET SIZE, BY 3D CONFORMAL RADIOTHERAPY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 75. GLOBAL RADIOTHERAPY MARKET SIZE, BY IMAGE-GUIDED RADIOTHERAPY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 76. GLOBAL RADIOTHERAPY MARKET SIZE, BY IMAGE-GUIDED RADIOTHERAPY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 77. GLOBAL RADIOTHERAPY MARKET SIZE, BY INTENSITY-MODULATED RADIOTHERAPY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 78. GLOBAL RADIOTHERAPY MARKET SIZE, BY INTENSITY-MODULATED RADIOTHERAPY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 79. GLOBAL RADIOTHERAPY MARKET SIZE, BY PARTICLE THERAPY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 80. GLOBAL RADIOTHERAPY MARKET SIZE, BY PARTICLE THERAPY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 81. GLOBAL RADIOTHERAPY MARKET SIZE, BY STEREOTACTIC THERAPY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 82. GLOBAL RADIOTHERAPY MARKET SIZE, BY STEREOTACTIC THERAPY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 83. GLOBAL RADIOTHERAPY MARKET SIZE, BY INSTILLATION RADIOTHERAPY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 84. GLOBAL RADIOTHERAPY MARKET SIZE, BY INSTILLATION RADIOTHERAPY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 85. GLOBAL RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY OR BRACHYTHERAPY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 86. GLOBAL RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY OR BRACHYTHERAPY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 87. GLOBAL RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY OR BRACHYTHERAPY, 2018-2023 (USD MILLION)
• TABLE 88. GLOBAL RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY OR BRACHYTHERAPY, 2024-2030 (USD MILLION)
• TABLE 89. GLOBAL RADIOTHERAPY MARKET SIZE, BY HIGH-DOSE-RATE BRACHYTHERAPY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 90. GLOBAL RADIOTHERAPY MARKET SIZE, BY HIGH-DOSE-RATE BRACHYTHERAPY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 91. GLOBAL RADIOTHERAPY MARKET SIZE, BY LOW-DOSE-RATE BRACHYTHERAPY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 92. GLOBAL RADIOTHERAPY MARKET SIZE, BY LOW-DOSE-RATE BRACHYTHERAPY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 93. GLOBAL RADIOTHERAPY MARKET SIZE, BY PULSED-DOSE-RATE BRACHYTHERAPY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 94. GLOBAL RADIOTHERAPY MARKET SIZE, BY PULSED-DOSE-RATE BRACHYTHERAPY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 95. GLOBAL RADIOTHERAPY MARKET SIZE, BY INTRAVENOUS RADIOTHERAPY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 96. GLOBAL RADIOTHERAPY MARKET SIZE, BY INTRAVENOUS RADIOTHERAPY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 97. GLOBAL RADIOTHERAPY MARKET SIZE, BY ORAL RADIOTHERAPY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 98. GLOBAL RADIOTHERAPY MARKET SIZE, BY ORAL RADIOTHERAPY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 99. GLOBAL RADIOTHERAPY MARKET SIZE, BY SYSTEMIC RADIOTHERAPY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 100. GLOBAL RADIOTHERAPY MARKET SIZE, BY SYSTEMIC RADIOTHERAPY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 101. GLOBAL RADIOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 102. GLOBAL RADIOTHERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 103. GLOBAL RADIOTHERAPY MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2023 (USD MILLION)
• TABLE 104. GLOBAL RADIOTHERAPY MARKET SIZE, BY BREAST CANCER, BY REGION, 2024-2030 (USD MILLION)
• TABLE 105. GLOBAL RADIOTHERAPY MARKET SIZE, BY CERVICAL CANCER, BY REGION, 2018-2023 (USD MILLION)
• TABLE 106. GLOBAL RADIOTHERAPY MARKET SIZE, BY CERVICAL CANCER, BY REGION, 2024-2030 (USD MILLION)
• TABLE 107. GLOBAL RADIOTHERAPY MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2018-2023 (USD MILLION)
• TABLE 108. GLOBAL RADIOTHERAPY MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2024-2030 (USD MILLION)
• TABLE 109. GLOBAL RADIOTHERAPY MARKET SIZE, BY GYNECOLOGICAL CANCER, BY REGION, 2018-2023 (USD MILLION)
• TABLE 110. GLOBAL RADIOTHERAPY MARKET SIZE, BY GYNECOLOGICAL CANCER, BY REGION, 2024-2030 (USD MILLION)
• TABLE 111. GLOBAL RADIOTHERAPY MARKET SIZE, BY HEAD & NECK CANCER, BY REGION, 2018-2023 (USD MILLION)
• TABLE 112. GLOBAL RADIOTHERAPY MARKET SIZE, BY HEAD & NECK CANCER, BY REGION, 2024-2030 (USD MILLION)
• TABLE 113. GLOBAL RADIOTHERAPY MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2023 (USD MILLION)
• TABLE 114. GLOBAL RADIOTHERAPY MARKET SIZE, BY LUNG CANCER, BY REGION, 2024-2030 (USD MILLION)
• TABLE 115. GLOBAL RADIOTHERAPY MARKET SIZE, BY PENILE CANCER, BY REGION, 2018-2023 (USD MILLION)
• TABLE 116. GLOBAL RADIOTHERAPY MARKET SIZE, BY PENILE CANCER, BY REGION, 2024-2030 (USD MILLION)
• TABLE 117. GLOBAL RADIOTHERAPY MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2023 (USD MILLION)
• TABLE 118. GLOBAL RADIOTHERAPY MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2024-2030 (USD MILLION)
• TABLE 119. GLOBAL RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 120. GLOBAL RADIOTHERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 121. GLOBAL RADIOTHERAPY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 122. GLOBAL RADIOTHERAPY MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 123. GLOBAL RADIOTHERAPY MARKET SIZE, BY INDEPENDENT RADIOTHERAPY CENTERS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 124. GLOBAL RADIOTHERAPY MARKET SIZE, BY INDEPENDENT RADIOTHERAPY CENTERS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 125. AMERICAS RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 126. AMERICAS RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 127. AMERICAS RADIOTHERAPY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 128. AMERICAS RADIOTHERAPY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 129. AMERICAS RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY/TELETHERAPY, 2018-2023 (USD MILLION)
• TABLE 130. AMERICAS RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY/TELETHERAPY, 2024-2030 (USD MILLION)
• TABLE 131. AMERICAS RADIOTHERAPY MARKET SIZE, BY LINEAR ACCELERATORS, 2018-2023 (USD MILLION)
• TABLE 132. AMERICAS RADIOTHERAPY MARKET SIZE, BY LINEAR ACCELERATORS, 2024-2030 (USD MILLION)
• TABLE 133. AMERICAS RADIOTHERAPY MARKET SIZE, BY PARTICLE THERAPY SYSTEMS, 2018-2023 (USD MILLION)
• TABLE 134. AMERICAS RADIOTHERAPY MARKET SIZE, BY PARTICLE THERAPY SYSTEMS, 2024-2030 (USD MILLION)
• TABLE 135. AMERICAS RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY, 2018-2023 (USD MILLION)
• TABLE 136. AMERICAS RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY, 2024-2030 (USD MILLION)
• TABLE 137. AMERICAS RADIOTHERAPY MARKET SIZE, BY SYSTEMIC RADIOTHERAPY, 2018-2023 (USD MILLION)
• TABLE 138. AMERICAS RADIOTHERAPY MARKET SIZE, BY SYSTEMIC RADIOTHERAPY, 2024-2030 (USD MILLION)
• TABLE 139. AMERICAS RADIOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2023 (USD MILLION)
• TABLE 140. AMERICAS RADIOTHERAPY MARKET SIZE, BY PROCEDURE, 2024-2030 (USD MILLION)
• TABLE 141. AMERICAS RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY, 2018-2023 (USD MILLION)
• TABLE 142. AMERICAS RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY, 2024-2030 (USD MILLION)
• TABLE 143. AMERICAS RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY OR BRACHYTHERAPY, 2018-2023 (USD MILLION)
• TABLE 144. AMERICAS RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY OR BRACHYTHERAPY, 2024-2030 (USD MILLION)
• TABLE 145. AMERICAS RADIOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 146. AMERICAS RADIOTHERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 147. AMERICAS RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 148. AMERICAS RADIOTHERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 149. AMERICAS RADIOTHERAPY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 150. AMERICAS RADIOTHERAPY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 151. ARGENTINA RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 152. ARGENTINA RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 153. ARGENTINA RADIOTHERAPY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 154. ARGENTINA RADIOTHERAPY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 155. ARGENTINA RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY/TELETHERAPY, 2018-2023 (USD MILLION)
• TABLE 156. ARGENTINA RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY/TELETHERAPY, 2024-2030 (USD MILLION)
• TABLE 157. ARGENTINA RADIOTHERAPY MARKET SIZE, BY LINEAR ACCELERATORS, 2018-2023 (USD MILLION)
• TABLE 158. ARGENTINA RADIOTHERAPY MARKET SIZE, BY LINEAR ACCELERATORS, 2024-2030 (USD MILLION)
• TABLE 159. ARGENTINA RADIOTHERAPY MARKET SIZE, BY PARTICLE THERAPY SYSTEMS, 2018-2023 (USD MILLION)
• TABLE 160. ARGENTINA RADIOTHERAPY MARKET SIZE, BY PARTICLE THERAPY SYSTEMS, 2024-2030 (USD MILLION)
• TABLE 161. ARGENTINA RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY, 2018-2023 (USD MILLION)
• TABLE 162. ARGENTINA RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY, 2024-2030 (USD MILLION)
• TABLE 163. ARGENTINA RADIOTHERAPY MARKET SIZE, BY SYSTEMIC RADIOTHERAPY, 2018-2023 (USD MILLION)
• TABLE 164. ARGENTINA RADIOTHERAPY MARKET SIZE, BY SYSTEMIC RADIOTHERAPY, 2024-2030 (USD MILLION)
• TABLE 165. ARGENTINA RADIOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2023 (USD MILLION)
• TABLE 166. ARGENTINA RADIOTHERAPY MARKET SIZE, BY PROCEDURE, 2024-2030 (USD MILLION)
• TABLE 167. ARGENTINA RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY, 2018-2023 (USD MILLION)
• TABLE 168. ARGENTINA RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY, 2024-2030 (USD MILLION)
• TABLE 169. ARGENTINA RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY OR BRACHYTHERAPY, 2018-2023 (USD MILLION)
• TABLE 170. ARGENTINA RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY OR BRACHYTHERAPY, 2024-2030 (USD MILLION)
• TABLE 171. ARGENTINA RADIOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 172. ARGENTINA RADIOTHERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 173. ARGENTINA RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 174. ARGENTINA RADIOTHERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 175. BRAZIL RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 176. BRAZIL RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 177. BRAZIL RADIOTHERAPY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 178. BRAZIL RADIOTHERAPY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 179. BRAZIL RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY/TELETHERAPY, 2018-2023 (USD MILLION)
• TABLE 180. BRAZIL RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY/TELETHERAPY, 2024-2030 (USD MILLION)
• TABLE 181. BRAZIL RADIOTHERAPY MARKET SIZE, BY LINEAR ACCELERATORS, 2018-2023 (USD MILLION)
• TABLE 182. BRAZIL RADIOTHERAPY MARKET SIZE, BY LINEAR ACCELERATORS, 2024-2030 (USD MILLION)
• TABLE 183. BRAZIL RADIOTHERAPY MARKET SIZE, BY PARTICLE THERAPY SYSTEMS, 2018-2023 (USD MILLION)
• TABLE 184. BRAZIL RADIOTHERAPY MARKET SIZE, BY PARTICLE THERAPY SYSTEMS, 2024-2030 (USD MILLION)
• TABLE 185. BRAZIL RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY, 2018-2023 (USD MILLION)
• TABLE 186. BRAZIL RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY, 2024-2030 (USD MILLION)
• TABLE 187. BRAZIL RADIOTHERAPY MARKET SIZE, BY SYSTEMIC RADIOTHERAPY, 2018-2023 (USD MILLION)
• TABLE 188. BRAZIL RADIOTHERAPY MARKET SIZE, BY SYSTEMIC RADIOTHERAPY, 2024-2030 (USD MILLION)
• TABLE 189. BRAZIL RADIOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2023 (USD MILLION)
• TABLE 190. BRAZIL RADIOTHERAPY MARKET SIZE, BY PROCEDURE, 2024-2030 (USD MILLION)
• TABLE 191. BRAZIL RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY, 2018-2023 (USD MILLION)
• TABLE 192. BRAZIL RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY, 2024-2030 (USD MILLION)
• TABLE 193. BRAZIL RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY OR BRACHYTHERAPY, 2018-2023 (USD MILLION)
• TABLE 194. BRAZIL RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY OR BRACHYTHERAPY, 2024-2030 (USD MILLION)
• TABLE 195. BRAZIL RADIOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 196. BRAZIL RADIOTHERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 197. BRAZIL RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 198. BRAZIL RADIOTHERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 199. CANADA RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 200. CANADA RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 201. CANADA RADIOTHERAPY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 202. CANADA RADIOTHERAPY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 203. CANADA RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY/TELETHERAPY, 2018-2023 (USD MILLION)
• TABLE 204. CANADA RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY/TELETHERAPY, 2024-2030 (USD MILLION)
• TABLE 205. CANADA RADIOTHERAPY MARKET SIZE, BY LINEAR ACCELERATORS, 2018-2023 (USD MILLION)
• TABLE 206. CANADA RADIOTHERAPY MARKET SIZE, BY LINEAR ACCELERATORS, 2024-2030 (USD MILLION)
• TABLE 207. CANADA RADIOTHERAPY MARKET SIZE, BY PARTICLE THERAPY SYSTEMS, 2018-2023 (USD MILLION)
• TABLE 208. CANADA RADIOTHERAPY MARKET SIZE, BY PARTICLE THERAPY SYSTEMS, 2024-2030 (USD MILLION)
• TABLE 209. CANADA RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY, 2018-2023 (USD MILLION)
• TABLE 210. CANADA RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY, 2024-2030 (USD MILLION)
• TABLE 211. CANADA RADIOTHERAPY MARKET SIZE, BY SYSTEMIC RADIOTHERAPY, 2018-2023 (USD MILLION)
• TABLE 212. CANADA RADIOTHERAPY MARKET SIZE, BY SYSTEMIC RADIOTHERAPY, 2024-2030 (USD MILLION)
• TABLE 213. CANADA RADIOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2023 (USD MILLION)
• TABLE 214. CANADA RADIOTHERAPY MARKET SIZE, BY PROCEDURE, 2024-2030 (USD MILLION)
• TABLE 215. CANADA RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY, 2018-2023 (USD MILLION)
• TABLE 216. CANADA RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY, 2024-2030 (USD MILLION)
• TABLE 217. CANADA RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY OR BRACHYTHERAPY, 2018-2023 (USD MILLION)
• TABLE 218. CANADA RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY OR BRACHYTHERAPY, 2024-2030 (USD MILLION)
• TABLE 219. CANADA RADIOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 220. CANADA RADIOTHERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 221. CANADA RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 222. CANADA RADIOTHERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 223. MEXICO RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 224. MEXICO RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 225. MEXICO RADIOTHERAPY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 226. MEXICO RADIOTHERAPY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 227. MEXICO RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY/TELETHERAPY, 2018-2023 (USD MILLION)
• TABLE 228. MEXICO RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY/TELETHERAPY, 2024-2030 (USD MILLION)
• TABLE 229. MEXICO RADIOTHERAPY MARKET SIZE, BY LINEAR ACCELERATORS, 2018-2023 (USD MILLION)
• TABLE 230. MEXICO RADIOTHERAPY MARKET SIZE, BY LINEAR ACCELERATORS, 2024-2030 (USD MILLION)
• TABLE 231. MEXICO RADIOTHERAPY MARKET SIZE, BY PARTICLE THERAPY SYSTEMS, 2018-2023 (USD MILLION)
• TABLE 232. MEXICO RADIOTHERAPY MARKET SIZE, BY PARTICLE THERAPY SYSTEMS, 2024-2030 (USD MILLION)
• TABLE 233. MEXICO RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY, 2018-2023 (USD MILLION)
• TABLE 234. MEXICO RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY, 2024-2030 (USD MILLION)
• TABLE 235. MEXICO RADIOTHERAPY MARKET SIZE, BY SYSTEMIC RADIOTHERAPY, 2018-2023 (USD MILLION)
• TABLE 236. MEXICO RADIOTHERAPY MARKET SIZE, BY SYSTEMIC RADIOTHERAPY, 2024-2030 (USD MILLION)
• TABLE 237. MEXICO RADIOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2023 (USD MILLION)
• TABLE 238. MEXICO RADIOTHERAPY MARKET SIZE, BY PROCEDURE, 2024-2030 (USD MILLION)
• TABLE 239. MEXICO RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY, 2018-2023 (USD MILLION)
• TABLE 240. MEXICO RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY, 2024-2030 (USD MILLION)
• TABLE 241. MEXICO RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY OR BRACHYTHERAPY, 2018-2023 (USD MILLION)
• TABLE 242. MEXICO RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY OR BRACHYTHERAPY, 2024-2030 (USD MILLION)
• TABLE 243. MEXICO RADIOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 244. MEXICO RADIOTHERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 245. MEXICO RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 246. MEXICO RADIOTHERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 247. UNITED STATES RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 248. UNITED STATES RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 249. UNITED STATES RADIOTHERAPY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 250. UNITED STATES RADIOTHERAPY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 251. UNITED STATES RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY/TELETHERAPY, 2018-2023 (USD MILLION)
• TABLE 252. UNITED STATES RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY/TELETHERAPY, 2024-2030 (USD MILLION)
• TABLE 253. UNITED STATES RADIOTHERAPY MARKET SIZE, BY LINEAR ACCELERATORS, 2018-2023 (USD MILLION)
• TABLE 254. UNITED STATES RADIOTHERAPY MARKET SIZE, BY LINEAR ACCELERATORS, 2024-2030 (USD MILLION)
• TABLE 255. UNITED STATES RADIOTHERAPY MARKET SIZE, BY PARTICLE THERAPY SYSTEMS, 2018-2023 (USD MILLION)
• TABLE 256. UNITED STATES RADIOTHERAPY MARKET SIZE, BY PARTICLE THERAPY SYSTEMS, 2024-2030 (USD MILLION)
• TABLE 257. UNITED STATES RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY, 2018-2023 (USD MILLION)
• TABLE 258. UNITED STATES RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY, 2024-2030 (USD MILLION)
• TABLE 259. UNITED STATES RADIOTHERAPY MARKET SIZE, BY SYSTEMIC RADIOTHERAPY, 2018-2023 (USD MILLION)
• TABLE 260. UNITED STATES RADIOTHERAPY MARKET SIZE, BY SYSTEMIC RADIOTHERAPY, 2024-2030 (USD MILLION)
• TABLE 261. UNITED STATES RADIOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2023 (USD MILLION)
• TABLE 262. UNITED STATES RADIOTHERAPY MARKET SIZE, BY PROCEDURE, 2024-2030 (USD MILLION)
• TABLE 263. UNITED STATES RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY, 2018-2023 (USD MILLION)
• TABLE 264. UNITED STATES RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY, 2024-2030 (USD MILLION)
• TABLE 265. UNITED STATES RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY OR BRACHYTHERAPY, 2018-2023 (USD MILLION)
• TABLE 266. UNITED STATES RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY OR BRACHYTHERAPY, 2024-2030 (USD MILLION)
• TABLE 267. UNITED STATES RADIOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 268. UNITED STATES RADIOTHERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 269. UNITED STATES RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 270. UNITED STATES RADIOTHERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 271. UNITED STATES RADIOTHERAPY MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
• TABLE 272. UNITED STATES RADIOTHERAPY MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
• TABLE 273. ASIA-PACIFIC RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 274. ASIA-PACIFIC RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 275. ASIA-PACIFIC RADIOTHERAPY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 276. ASIA-PACIFIC RADIOTHERAPY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 277. ASIA-PACIFIC RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY/TELETHERAPY, 2018-2023 (USD MILLION)
• TABLE 278. ASIA-PACIFIC RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY/TELETHERAPY, 2024-2030 (USD MILLION)
• TABLE 279. ASIA-PACIFIC RADIOTHERAPY MARKET SIZE, BY LINEAR ACCELERATORS, 2018-2023 (USD MILLION)
• TABLE 280. ASIA-PACIFIC RADIOTHERAPY MARKET SIZE, BY LINEAR ACCELERATORS, 2024-2030 (USD MILLION)
• TABLE 281. ASIA-PACIFIC RADIOTHERAPY MARKET SIZE, BY PARTICLE THERAPY SYSTEMS, 2018-2023 (USD MILLION)
• TABLE 282. ASIA-PACIFIC RADIOTHERAPY MARKET SIZE, BY PARTICLE THERAPY SYSTEMS, 2024-2030 (USD MILLION)
• TABLE 283. ASIA-PACIFIC RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY, 2018-2023 (USD MILLION)
• TABLE 284. ASIA-PACIFIC RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY, 2024-2030 (USD MILLION)
• TABLE 285. ASIA-PACIFIC RADIOTHERAPY MARKET SIZE, BY SYSTEMIC RADIOTHERAPY, 2018-2023 (USD MILLION)
• TABLE 286. ASIA-PACIFIC RADIOTHERAPY MARKET SIZE, BY SYSTEMIC RADIOTHERAPY, 2024-2030 (USD MILLION)
• TABLE 287. ASIA-PACIFIC RADIOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2023 (USD MILLION)
• TABLE 288. ASIA-PACIFIC RADIOTHERAPY MARKET SIZE, BY PROCEDURE, 2024-2030 (USD MILLION)
• TABLE 289. ASIA-PACIFIC RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY, 2018-2023 (USD MILLION)
• TABLE 290. ASIA-PACIFIC RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY, 2024-2030 (USD MILLION)
• TABLE 291. ASIA-PACIFIC RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY OR BRACHYTHERAPY, 2018-2023 (USD MILLION)
• TABLE 292. ASIA-PACIFIC RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY OR BRACHYTHERAPY, 2024-2030 (USD MILLION)
• TABLE 293. ASIA-PACIFIC RADIOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 294. ASIA-PACIFIC RADIOTHERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 295. ASIA-PACIFIC RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 296. ASIA-PACIFIC RADIOTHERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 297. ASIA-PACIFIC RADIOTHERAPY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 298. ASIA-PACIFIC RADIOTHERAPY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 299. AUSTRALIA RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 300. AUSTRALIA RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 301. AUSTRALIA RADIOTHERAPY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 302. AUSTRALIA RADIOTHERAPY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 303. AUSTRALIA RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY/TELETHERAPY, 2018-2023 (USD MILLION)
• TABLE 304. AUSTRALIA RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY/TELETHERAPY, 2024-2030 (USD MILLION)
• TABLE 305. AUSTRALIA RADIOTHERAPY MARKET SIZE, BY LINEAR ACCELERATORS, 2018-2023 (USD MILLION)
• TABLE 306. AUSTRALIA RADIOTHERAPY MARKET SIZE, BY LINEAR ACCELERATORS, 2024-2030 (USD MILLION)
• TABLE 307. AUSTRALIA RADIOTHERAPY MARKET SIZE, BY PARTICLE THERAPY SYSTEMS, 2018-2023 (USD MILLION)
• TABLE 308. AUSTRALIA RADIOTHERAPY MARKET SIZE, BY PARTICLE THERAPY SYSTEMS, 2024-2030 (USD MILLION)
• TABLE 309. AUSTRALIA RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY, 2018-2023 (USD MILLION)
• TABLE 310. AUSTRALIA RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY, 2024-2030 (USD MILLION)
• TABLE 311. AUSTRALIA RADIOTHERAPY MARKET SIZE, BY SYSTEMIC RADIOTHERAPY, 2018-2023 (USD MILLION)
• TABLE 312. AUSTRALIA RADIOTHERAPY MARKET SIZE, BY SYSTEMIC RADIOTHERAPY, 2024-2030 (USD MILLION)
• TABLE 313. AUSTRALIA RADIOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2023 (USD MILLION)
• TABLE 314. AUSTRALIA RADIOTHERAPY MARKET SIZE, BY PROCEDURE, 2024-2030 (USD MILLION)
• TABLE 315. AUSTRALIA RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY, 2018-2023 (USD MILLION)
• TABLE 316. AUSTRALIA RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY, 2024-2030 (USD MILLION)
• TABLE 317. AUSTRALIA RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY OR BRACHYTHERAPY, 2018-2023 (USD MILLION)
• TABLE 318. AUSTRALIA RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY OR BRACHYTHERAPY, 2024-2030 (USD MILLION)
• TABLE 319. AUSTRALIA RADIOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 320. AUSTRALIA RADIOTHERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 321. AUSTRALIA RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 322. AUSTRALIA RADIOTHERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 323. CHINA RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 324. CHINA RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 325. CHINA RADIOTHERAPY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 326. CHINA RADIOTHERAPY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 327. CHINA RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY/TELETHERAPY, 2018-2023 (USD MILLION)
• TABLE 328. CHINA RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY/TELETHERAPY, 2024-2030 (USD MILLION)
• TABLE 329. CHINA RADIOTHERAPY MARKET SIZE, BY LINEAR ACCELERATORS, 2018-2023 (USD MILLION)
• TABLE 330. CHINA RADIOTHERAPY MARKET SIZE, BY LINEAR ACCELERATORS, 2024-2030 (USD MILLION)
• TABLE 331. CHINA RADIOTHERAPY MARKET SIZE, BY PARTICLE THERAPY SYSTEMS, 2018-2023 (USD MILLION)
• TABLE 332. CHINA RADIOTHERAPY MARKET SIZE, BY PARTICLE THERAPY SYSTEMS, 2024-2030 (USD MILLION)
• TABLE 333. CHINA RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY, 2018-2023 (USD MILLION)
• TABLE 334. CHINA RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY, 2024-2030 (USD MILLION)
• TABLE 335. CHINA RADIOTHERAPY MARKET SIZE, BY SYSTEMIC RADIOTHERAPY, 2018-2023 (USD MILLION)
• TABLE 336. CHINA RADIOTHERAPY MARKET SIZE, BY SYSTEMIC RADIOTHERAPY, 2024-2030 (USD MILLION)
• TABLE 337. CH

[196 Pages Report] The Radiotherapy Market size was estimated at USD 6.64 billion in 2023 and expected to reach USD 7.03 billion in 2024, at a CAGR 6.04% to reach USD 10.01 billion by 2030.

Radiotherapy comprises businesses in the medical and healthcare sectors that harness radiation as a mode of treatment, typically for cancer and some non-malignant conditions. It involves deploying high-energy radiation, such as X-rays, gamma rays, and charged particles, primarily destroying cancerous cells, minimizing their growth, and reducing symptoms in palliative cases. The growing adoption of radiotherapy procedures for cancer treatment and rising preference for minimally invasive procedures influence the development of radiotherapy. In contrast, high treatment costs, limited availability of trained professionals, and risks associated with radiation exposure are restricting the utilization of radiotherapy. However, several vendors are working and investing in R&D to overcome these issues. Furthermore, technological advancements and improvements in radiotherapy devices and the introduction of robotic radiotherapy systems for cancer treatment are opportunities for businesses to create and market cutting-edge devices.

Product: Advancements in hardware manufacturing process as it provide high radiation doses to the tumor site

The hardware encapsulates all the tangible elements employed in administering radiotherapy treatment. These include linear accelerators, brachytherapy devices, proton therapy, and cyber knife systems. The software and service segment refers to the platforms used to plan treatment protocols, simulate radiation doses, and manage patient data and analytics. Services encompass various support functions, including equipment maintenance, training, technical support, and consulting. In comparison, the hardware provides the physical means to deliver treatment, while software & service ensure precise targeting, dose planning, and seamless operation.

Type: Consumer preference for external beam radiotherapy/teletherapy as they target tumor from outside and large tumors

External beam radiotherapy (EBRT)/ teletherapy is a common form of radiation treatment where the radiation originates outside the patient and is directed toward the cancer site. Conventional cobalt-60 teletherapy units provide continuously rotating radiation therapy for cancer treatment and are highly efficient with deeper penetration capabilities. Linear accelerators (LINACs) deliver high-energy X-rays to the patient's tumor region, damaging the cancerous cells' genetic material and disrupting their growth. Conventional linear accelerators utilize microwave technology to accelerate electrons before colliding them with a heavy metal target, thus generating high-energy X-rays. Cyberknife tomotherapy allows precision treatment through a robotic arm that delivers multiple angles of radiation to a tumor. The system modulates the radiation dose, minimizing the impact on healthy tissue. Gamma knife has exact doses of radiation to the affected area, reducing damage to healthy brain tissues. MRI Linac allows clinicians to visualize the tumor in real-time during treatment and adapt therapy as needed. Stereotactic advanced electron/cobalt-60 linear accelerators deliver high doses of radiation from multiple angles to treat a small area with pinpoint accuracy, minimizing the impact on surrounding healthy tissues. Particle therapy systems use charged particles to target cancer cells precisely, minimizing the radiation dose to nearby healthy tissue and potentially reducing the risk of side effects. Internal beam radiotherapy/Brachytherapy involves radiation delivery directly into and near the cancer site, providing a high radiation dose while sparing surrounding healthy tissues. It's often the top choice for treating localized cancers such as prostate and cervical cancers. Afterloaders aim to reduce exposure to radiation health professionals, enhancing policies for patient safety and increasing treatment precision. Applicators are designed instruments intended to aid in positioning the radiation sources into the treatment site in a patient's body. Intraoperative radiation therapy (IORT) systems are advanced radiotherapeutic devices used during surgeries for localized cancer treatment. Seeds are tiny devices that encase radioactive materials. When carefully implanted into cancerous tissues, these seeds can deliver radiation directly to the tumor, minimizing damage to nearby healthy tissues.

Iobenguane (I-131) is a type of molecule that is selectively absorbed by certain types of nervous tissues. This unique characteristic makes it an invaluable tool in diagnosing and treating neuroendocrine tumors. Rhenium-186 isotope takes advanced medical science a step further by the exemplary way its gamma radiation properties enable medical professionals to track its effectiveness in patients with medical imaging technology. Samarium-153 has a dual capacity, its beta particles target and destroy cancer cells, its gamma emissions facilitate imaging and tracking its distribution through the body.

Procedure: Increasing advancements in external beam radiotherapy to streamline process and improve patient comfort

External Beam Radiotherapy (EBRT) is the most typical radiotherapy used to treat various cancers. 3D conformal radiotherapy effectively treats many types of cancers and is well-regarded for its precision and ability to minimize side effects. Image-guided Radiotherapy (IGRT) is an advanced form of radiotherapy involving imaging techniques during treatment delivery. Intensity-modulated Radiotherapy (IMRT) allows the radiotherapy beam to be optimized to the tumor's shape, allowing differing degrees of radiation intensity to various parts of the cancer. Particle therapy uniquely uses charged atomic particles, providing a low dose to the tissues they pass through and then depositing their energy at a precise point. Stereotactic therapy allows for high-dose delivery, particularly to small, well-defined tumors in the brain and other sites, while minimizing the radiation to adjacent normal tissues, thus mitigating potential side effects. Instillation radiotherapy involves injecting a radioactive substance directly into a body cavity or the bladder to treat superficial cancers. Brachytherapy is radiotherapy where the radioactive source is placed inside or next to the tumor, ensuring high-dose radiation while sparing healthy tissues. High-dose-rate (HDR) brachytherapy aims to destroy cancer cells while minimizing the exposure and damage to surrounding healthy tissues. LDR brachytherapy has been extensively used for treating numerous types of cancers, including cervical, prostate, and eye cancer. Pulsed-dose-rate (PDR) brachytherapy involves temporally confined radiation delivery cycles where radiation is emitted in pulses, usually once per hour. This technique seeks to maximize the tumor's dose delivery while safeguarding the surrounding healthy tissue. Intravenous Radiotherapy involves administering liquid radioactive substances into the body via a vein. This treatment is typically used for cancers that have spread or metastasized. Oral Radiotherapy involves ingesting radioactive substances through a pill or liquid. Notable for treating conditions such as thyroid cancer. Systemic radiotherapy uses radiopharmaceuticals that circulate throughout the body, ideal for treating cancers that have spread to bones or multiple sites.

Application: Growing application of radiotherapy for gynecological cancer

Radiotherapy plays a substantial role in breast cancer treatment, substantially reducing the reoccurrence risk within the breast area after surgery. Cervical cancer treatment frequently incorporates radiotherapy either alone or combined with chemotherapy. The need for radiotherapy heavily relies on the cancer stage and localization. Radiotherapy for colorectal cancer treatment is used before surgery to shrink the tumor and after the surgery to kill the remaining cells. Radiation therapy is commonly used to treat various types of gynecological cancers. Depending upon the type and stage of the cancer, radiation is used as primary therapy, adjunctive therapy, or palliative therapy. Radiotherapy is crucial in managing head and neck cancers, often in conjunction with surgery and chemotherapy. Radiotherapy for lung cancer serves as a primary mode of treatment. Penile cancer, although rare, often uses radiation therapy as a primary or supplementary treatment. Radiotherapy is very effective in curative treatment of localized prostate cancer. In comparison, radiotherapy is mostly used for gynecological cancer as it results in local control and survival with few complications.

End-User: Significant role of radiotherapy for hospitals service as they provide comprehensive care for cancer patients

Hospitals provide comprehensive care for cancer patients, including diagnostic and therapeutic services. The offering of radiotherapy as an integrated service within the hospital setting allows for better coordination of care, leading to improved patient outcomes. Independent radiotherapy centers are specialized clinics that offer radiation therapy to cancer patients. These centers provide patients with more personalized and convenient care. While these entities may offer a partial range of services, hospitals can often provide radiotherapy treatment more efficiently and patient-centeredly. Hospitals typically have a broader range of services, enabling them to provide holistic care, drawing patients dealing with multiple health issues. On the other hand, independent radiotherapy centers offer a more patient-centric approach, preferred by patients only seeking radiotherapy.

Regional Insights

The adoption of radiotherapy in the Americas is driven by various factors, primarily increasing cancer prevalence rates and a general preference for non-invasive treatment methods. Advanced technologies such as 3D conformal radiotherapy (3D CRT) and intensity-modulated radiotherapy (IMRT) contribute to this market's growth. Simultaneously, government initiatives focusing on cancer prevention and control are a significant factor behind this market's expansion. EMEA region has an increasing need for radiotherapy due to rising cancer incidents. With diverse cancer cases observed across the region, radiotherapy becomes a preferred treatment solution, offering targeted and efficient treatment outcomes. Regulatory approvals for innovative radiotherapy devices, the proliferation of cancer research, and robust healthcare frameworks further bolster the market. The APAC region is witnessing a rapid expansion in the radiotherapy market driven by the escalating burden of cancer. Several countries have high cancer rates, fueling the need for effective treatment modalities, including radiotherapy. The sector's growth is amplified by increasing awareness about early diagnosis, improved access to cancer treatments, and technological advancements within this domain. APAC's emerging economies are also investing heavily in healthcare infrastructure, which further propels the adoption of radiotherapy.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Radiotherapy Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Radiotherapy Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Radiotherapy Market, highlighting leading vendors and their innovative profiles. These include Accuray Incorporated, Agilent Technologies Inc., Becton, Dickinson and Company, Cardinal Health, Inc., Charles River Laboratories International, Inc., Elekta AB, F. Hoffmann-La Roche Ltd., GE HealthCare Technologies Inc., IBA Dosimetry GmbH, IntraOp Medical, Inc., Koninklijke Philips N.V., Leo Cancer Care, Mevion Medical Systems, Panacea Medical Technologies Pvt. Ltd., PerkinElmer, Inc., Qfix, Quanterix Corporation, Radiology Oncology Systems, Siemens AG, Varian Medical Systems, Inc., ViewRay Technologies, Inc., and ZEISS Group.

Market Segmentation & Coverage

This research report categorizes the Radiotherapy Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Product
  • Hardware
  • Software & Service

• Type
  • External Beam Radiotherapy/Teletherapy
    • Conventional Cabalt-60 Teletherapy Units
    • Linear Accelerators
      • Conventional Linear Accelerators
      • CyberKnife TomoTherapy
      • Gamma Knife
      • MRI LINAC
      • Stereotactic Advanced Electron/Cobalt-60 Linear Accelerators

• Particle Therapy Systems
  • Cyclotrons
  • Synchrocyclotron
  • Synchrotrons
• Internal Beam Radiotherapy/Brachytherapy
  • Afterloaders
  • Applicators
  • IORT Systems
  • Seeds

• Systemic Radiotherapy
  • lobenguane (l-131)
  • Rhenium-186
  • Samarium-153
• Procedure
  • External Beam Radiotherapy
    • 3D Conformal Radiotherapy
    • Image-Guided Radiotherapy
    • Intensity-Modulated Radiotherapy
    • Particle Therapy
    • Stereotactic Therapy

• Instillation Radiotherapy
• Internal Beam Radiotherapy or Brachytherapy
  • High-Dose-Rate Brachytherapy
  • Low-Dose-Rate Brachytherapy
  • Pulsed-Dose-Rate Brachytherapy

• Intravenous Radiotherapy
• Oral Radiotherapy
• Systemic Radiotherapy

• Application
  • Breast Cancer
  • Cervical Cancer
  • Colorectal Cancer
  • Gynecological Cancer
  • Head & Neck Cancer
  • Lung Cancer
  • Penile Cancer
  • Prostate Cancer

• End-User
  • Hospitals
  • Independent Radiotherapy Centers

• Region
  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam

• Europe, Middle East & Africa
  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Radiotherapy Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Radiotherapy Market?

3. What are the technology trends and regulatory frameworks in the Radiotherapy Market?

4. What is the market share of the leading vendors in the Radiotherapy Market?

5. Which modes and strategic moves are suitable for entering the Radiotherapy Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing adoption of radiotherapy procedures for cancer treatment
    • 5.1.1.2. Rising preference for minimally invasive procedures
    • 5.1.1.3. Increasing government initiatives and programs for radiotherapy
  • 5.1.2. Restraints
    • 5.1.2.1. High treatment costs and limited availability of trained professionals
  • 5.1.3. Opportunities
    • 5.1.3.1. Technological advancements and improvements in radiotherapy devices
    • 5.1.3.2. Introduction of robotic radiotherapy systems for cancer treatment
  • 5.1.4. Challenges
    • 5.1.4.1. Risks associated with radiation exposure
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Advancements in hardware manufacturing process as it provide high radiation doses to the tumor site
  • 5.2.2. Type: Consumer preference for external beam radiotherapy/teletherapy as they target tumor from outside and large tumors
  • 5.2.3. Procedure: Increasing advancements in external beam radiotherapy to streamline process and improve patient comfort
  • 5.2.4. Application: Growing application of radiotherapy for gynecological cancer
  • 5.2.5. End-User: Significant role of radiotherapy for hospitals service as they provide comprehensive care for cancer patients
• 5.3. Market Disruption Analysis
• 5.4. Porter's Five Forces Analysis
  • 5.4.1. Threat of New Entrants
  • 5.4.2. Threat of Substitutes
  • 5.4.3. Bargaining Power of Customers
  • 5.4.4. Bargaining Power of Suppliers
  • 5.4.5. Industry Rivalry
• 5.5. Value Chain & Critical Path Analysis
• 5.6. Pricing Analysis
• 5.7. Technology Analysis
• 5.8. Patent Analysis
• 5.9. Trade Analysis
• 5.10. Regulatory Framework Analysis

6. Radiotherapy Market, by Product

• 6.1. Introduction
• 6.2. Hardware
• 6.3. Software & Service

7. Radiotherapy Market, by Type

• 7.1. Introduction
• 7.2. External Beam Radiotherapy/Teletherapy
• 7.3. Internal Beam Radiotherapy/Brachytherapy
• 7.4. Systemic Radiotherapy

8. Radiotherapy Market, by Procedure

• 8.1. Introduction
• 8.2. External Beam Radiotherapy
• 8.3. Instillation Radiotherapy
• 8.4. Internal Beam Radiotherapy or Brachytherapy
• 8.5. Intravenous Radiotherapy
• 8.6. Oral Radiotherapy
• 8.7. Systemic Radiotherapy

9. Radiotherapy Market, by Application

• 9.1. Introduction
• 9.2. Breast Cancer
• 9.3. Cervical Cancer
• 9.4. Colorectal Cancer
• 9.5. Gynecological Cancer
• 9.6. Head & Neck Cancer
• 9.7. Lung Cancer
• 9.8. Penile Cancer
• 9.9. Prostate Cancer

10. Radiotherapy Market, by End-User

• 10.1. Introduction
• 10.2. Hospitals
• 10.3. Independent Radiotherapy Centers

11. Americas Radiotherapy Market

• 11.1. Introduction
• 11.2. Argentina
• 11.3. Brazil
• 11.4. Canada
• 11.5. Mexico
• 11.6. United States

12. Asia-Pacific Radiotherapy Market

• 12.1. Introduction
• 12.2. Australia
• 12.3. China
• 12.4. India
• 12.5. Indonesia
• 12.6. Japan
• 12.7. Malaysia
• 12.8. Philippines
• 12.9. Singapore
• 12.10. South Korea
• 12.11. Taiwan
• 12.12. Thailand
• 12.13. Vietnam

13. Europe, Middle East & Africa Radiotherapy Market

• 13.1. Introduction
• 13.2. Denmark
• 13.3. Egypt
• 13.4. Finland
• 13.5. France
• 13.6. Germany
• 13.7. Israel
• 13.8. Italy
• 13.9. Netherlands
• 13.10. Nigeria
• 13.11. Norway
• 13.12. Poland
• 13.13. Qatar
• 13.14. Russia
• 13.15. Saudi Arabia
• 13.16. South Africa
• 13.17. Spain
• 13.18. Sweden
• 13.19. Switzerland
• 13.20. Turkey
• 13.21. United Arab Emirates
• 13.22. United Kingdom

14. Competitive Landscape

• 14.1. Market Share Analysis, 2023
• 14.2. FPNV Positioning Matrix, 2023
• 14.3. Competitive Scenario Analysis
  • 14.3.1. CIVCO Radiotherapy and Qfix Launch CQ Medical Brand
  • 14.3.2. GE HealthCare Collaborates with Elekta to Expand Access to Precision Radiation Therapy Solutions in India
  • 14.3.3. IBA Launches Latest Radiation Therapy Quality Assurance Offerings
• 14.4. Strategy Analysis & Recommendation

15. Competitive Portfolio

• 15.1. Key Company Profiles
• 15.2. Key Product Portfolio